Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
2019 1
2020 2
2022 1
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Real-world experience with secukinumab in the entire axial spondyloarthritis spectrum.
Sivera F, Núñez-Monje V, Campos-Fernández C, Balaguer-Trull I, Robustillo-Villarino M, Aguilar-Zamora M, Garijo-Bufort M, López-Gómez JM, Peña-González C, de la Morena I, Bedoya-Sanchís D, Yankova-Komsalova L, Conesa-Mateos A, Martínez-Cristóbal A, Navarro-Blasco FJ, Senabre-Gallego JM, Alegre-Sancho JJ. Sivera F, et al. Among authors: de la morena i. Front Med (Lausanne). 2023 May 11;10:1156557. doi: 10.3389/fmed.2023.1156557. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37250652 Free PMC article.
Real-world effectiveness and persistence of secukinumab in the treatment of patients with psoriatic arthritis.
Alegre-Sancho JJ, Núñez-Monje V, Campos-Fernández C, Balaguer-Trull I, Robustillo-Villarino M, Aguilar-Zamora M, Garijo-Bufort M, Pedraz-Penalva T, Peña-González C, de la Morena I, Bedoya-Sanchís D, Yankova-Komsalova L, Conesa-Mateos A, Martinez-Cristóbal A, Navarro-Blasco FJ, Senabre-Gallego JM, Sivera F. Alegre-Sancho JJ, et al. Among authors: de la morena i. Front Med (Lausanne). 2023 Nov 20;10:1294247. doi: 10.3389/fmed.2023.1294247. eCollection 2023. Front Med (Lausanne). 2023. PMID: 38053615 Free PMC article.
Optimisation of tocilizumab therapy in giant cell arteritis. A multicentre real-life study of 471 patients.
Calderón-Goercke M, Loricera J, Moriano C, Castañeda S, Narváez J, Aldasoro V, Maiz O, Melero R, Villa JI, Vela P, Romero-Yuste S, Callejas JL, de Miguel E, Galíndez-Agirregoikoa E, Sivera F, Fernández-López JC, Galisteo C, Ferraz-Amaro I, Sanchéz-Martín J, Sánchez-Bilbao L, González-Gay MA, Hernández JL, Blanco R; Tocilizumab in Giant Cell Arteritis Spanish Collaborative Group. Calderón-Goercke M, et al. Clin Exp Rheumatol. 2023 Apr;41(4):829-836. doi: 10.55563/clinexprheumatol/oqs8u9. Epub 2022 Nov 2. Clin Exp Rheumatol. 2023. PMID: 36377586 Free article.
Using natural language processing to explore characteristics and management of patients with axial spondyloarthritis and psoriatic arthritis treated under real-world conditions in Spain: SpAINET study.
Benavent D, Muñoz-Fernández S, De la Morena I, Fernández-Nebro A, Marín-Corral J, Castillo Rosa E, Taberna M, Sanabra C, Sastre C; SAVANA Research Group. Benavent D, et al. Among authors: de la morena i. Ther Adv Musculoskelet Dis. 2023 Dec 24;15:1759720X231220818. doi: 10.1177/1759720X231220818. eCollection 2023. Ther Adv Musculoskelet Dis. 2023. PMID: 38146537 Free PMC article.